{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T12:45:49Z","timestamp":1769517949395,"version":"3.49.0"},"reference-count":134,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2005,1]]},"DOI":"10.1016\/j.ejogrb.2004.06.024","type":"journal-article","created":{"date-parts":[[2004,11,18]],"date-time":"2004-11-18T01:37:05Z","timestamp":1100741825000},"page":"4-16","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["PCOS: an ovarian disorder that leads to dysregulation in the hypothalamic\u2013pituitary\u2013adrenal axis?"],"prefix":"10.1016","volume":"118","author":[{"given":"Suhail A.R.","family":"Doi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip A.","family":"Towers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher J.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamal A.S.","family":"Al-Shoumer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ejogrb.2004.06.024_bib1","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1053\/beem.2002.0203","article-title":"Adult polycystic ovary syndrome begins in childhood","volume":"16","author":"Franks","year":"2002","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.ejogrb.2004.06.024_bib2","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1080\/1464727022000199881","article-title":"Polycystic ovary syndrome: not ovarian, not simple, unkind","volume":"5","author":"Fox","year":"2002","journal-title":"Hum Fertil (Camb)"},{"issue":"5","key":"10.1016\/j.ejogrb.2004.06.024_bib3","doi-asserted-by":"crossref","first-page":"386","DOI":"10.7326\/0003-4819-110-5-386","article-title":"The polycystic ovary syndrome: pathogenesis and treatment","volume":"110","author":"Barnes","year":"1989","journal-title":"Ann Intern Med"},{"issue":"9","key":"10.1016\/j.ejogrb.2004.06.024_bib4","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1056\/NEJM198903023200904","article-title":"Pituitary\u2013ovarian responses to nafarelin testing in the polycystic ovary syndrome","volume":"320","author":"Barnes","year":"1989","journal-title":"N Engl J Med."},{"issue":"2","key":"10.1016\/j.ejogrb.2004.06.024_bib5","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0950-3552(97)80039-9","article-title":"Current concepts of polycystic ovary syndrome","volume":"11","author":"Rosenfield","year":"1997","journal-title":"Baillieres Clin Obstet Gynaecol"},{"issue":"3","key":"10.1016\/j.ejogrb.2004.06.024_bib6","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1056\/NEJM199207163270304","article-title":"Detection of functional ovarian hyperandrogenism in women with androgen excess","volume":"327","author":"Ehrmann","year":"1992","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.ejogrb.2004.06.024_bib7","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0015-0282(98)00455-5","article-title":"Do hyperandrogenic women with normal menses have polycystic ovary syndrome?","volume":"71","author":"Carmina","year":"1999","journal-title":"Fertil Steril"},{"issue":"5","key":"10.1016\/j.ejogrb.2004.06.024_bib8","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1093\/humrep\/12.5.905","article-title":"Endocrine abnormalities in ovulatory women with polycystic ovaries on ultrasound","volume":"12","author":"Carmina","year":"1997","journal-title":"Hum Reprod"},{"issue":"3","key":"10.1016\/j.ejogrb.2004.06.024_bib9","first-page":"995","article-title":"Normal ovulatory women with polycystic ovaries have hyperandrogenic pituitary\u2013ovarian responses to gonadotropin-releasing hormone-agonist testing","volume":"85","author":"Chang","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"25","key":"10.1016\/j.ejogrb.2004.06.024_bib10","doi-asserted-by":"crossref","first-page":"14956","DOI":"10.1073\/pnas.95.25.14956","article-title":"Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome","volume":"95","author":"Legro","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.ejogrb.2004.06.024_bib11","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","year":"2004","journal-title":"Fertil Steril"},{"issue":"12","key":"10.1016\/j.ejogrb.2004.06.024_bib12","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1056\/NEJM197603182941204","article-title":"Idiopathic hirsutism\u2014an ovarian abnormality","volume":"294","author":"Kirschner","year":"1976","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.ejogrb.2004.06.024_bib13","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/S0188-4409(01)00325-3","article-title":"Mechanisms of hypothalamic\u2013pituitary\u2013gonadal disruption in polycystic ovarian syndrome","volume":"32","author":"Barontini","year":"2001","journal-title":"Arch Med Res"},{"issue":"6","key":"10.1016\/j.ejogrb.2004.06.024_bib14","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/j.1365-2265.1992.tb02266.x","article-title":"17beta-Oestradiol, androstenedione and inhibin levels in fluid from individual follicles of normal and polycystic ovaries, and in ovaries from androgen treated female to male transsexuals","volume":"36","author":"Pache","year":"1992","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"10.1016\/j.ejogrb.2004.06.024_bib15","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1046\/j.1365-2265.1998.00442.x","article-title":"Inhibin A and inhibin B in women with polycystic ovarian syndrome during treatment with FSH to induce mono-ovulation","volume":"48","author":"Anderson","year":"1998","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"10.1016\/j.ejogrb.2004.06.024_bib16","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1210\/jcem-45-4-798","article-title":"Pituitary\u2013ovarian relationships in polycystic ovary syndrome","volume":"45","author":"Baird","year":"1977","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.ejogrb.2004.06.024_bib17","first-page":"39","article-title":"Treatment of polycystic ovary disease with chronic low-dose follicle stimulating hormone: biochemical changes and ultrasound correlation","volume":"29","author":"Seibel","year":"1984","journal-title":"Int J Fertil"},{"issue":"6","key":"10.1016\/j.ejogrb.2004.06.024_bib18","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/S0015-0282(16)54351-9","article-title":"Polycystic ovarian syndrome: safety and effectiveness of stepwise and low-dose administration of purified follicle-stimulating hormone","volume":"55","author":"Shoham","year":"1991","journal-title":"Fertil Steril"},{"issue":"8","key":"10.1016\/j.ejogrb.2004.06.024_bib19","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1093\/oxfordjournals.humrep.a137491","article-title":"Low-dose gonadotrophin therapy for induction of ovulation in 100 women with polycystic ovary syndrome","volume":"6","author":"Hamilton-Fairley","year":"1991","journal-title":"Hum Reprod"},{"issue":"7","key":"10.1016\/j.ejogrb.2004.06.024_bib20","first-page":"2742","article-title":"Decreased inhibin B secretion is associated with the monotropic FSH rise in older, ovulatory women: a study of serum and follicular fluid levels of dimeric inhibin A and B in spontaneous menstrual cycles","volume":"81","author":"Klein","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.ejogrb.2004.06.024_bib21","first-page":"105","article-title":"Female reproductive aging is marked by decreased secretion of dimeric inhibin","volume":"84","author":"Welt","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.ejogrb.2004.06.024_bib22","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0015-0282(98)00127-7","article-title":"Dimeric inhibin: a direct marker of ovarian aging","volume":"70","author":"Danforth","year":"1998","journal-title":"Fertil Steril"},{"issue":"4","key":"10.1016\/j.ejogrb.2004.06.024_bib23","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0889-8529(05)70286-3","article-title":"Polycystic ovary syndrome","volume":"26","author":"Goudas","year":"1997","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"4","key":"10.1016\/j.ejogrb.2004.06.024_bib24","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1210\/jcem-66-4-798","article-title":"Serum inhibin levels in polycystic ovary syndrome: basal levels and response to luteinizing hormone-releasing hormone agonist and exogenous gonadotropin administration","volume":"66","author":"Buckler","year":"1988","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.ejogrb.2004.06.024_bib25","first-page":"669","article-title":"Biological and immunological characterization of inhibin forms in human plasma","volume":"81","author":"Robertson","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.ejogrb.2004.06.024_bib26","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1677\/joe.0.1440261","article-title":"Inhibin forms in human plasma","volume":"144","author":"Robertson","year":"1995","journal-title":"J Endocrinol"},{"issue":"4","key":"10.1016\/j.ejogrb.2004.06.024_bib27","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1093\/humrep\/16.4.668","article-title":"Circulating follistatin concentrations are higher and activin concentrations are lower in polycystic ovarian syndrome","volume":"16","author":"Norman","year":"2001","journal-title":"Hum Reprod"},{"issue":"5","key":"10.1016\/j.ejogrb.2004.06.024_bib28","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/S0015-0282(00)00421-0","article-title":"Serum levels of inhibins are differentially altered in patients with polycystic ovary syndrome: effects of being overweight and relevance to hyperandrogenism","volume":"73","author":"Pigny","year":"2000","journal-title":"Fertil Steril"},{"issue":"7","key":"10.1016\/j.ejogrb.2004.06.024_bib29","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1093\/humrep\/16.7.1359","article-title":"Absent biologically relevant associations between serum inhibin B concentrations and characteristics of polycystic ovary syndrome in normogonadotrophic anovulatory infertility","volume":"16","author":"Laven","year":"2001","journal-title":"Hum Reprod"},{"issue":"2","key":"10.1016\/j.ejogrb.2004.06.024_bib30","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0015-0282(01)02968-5","article-title":"Obesity and serum luteinizing hormone level have an independent and opposite effect on the serum inhibin B level in patients with polycystic ovary syndrome","volume":"77","author":"Cortet-Rudelli","year":"2002","journal-title":"Fertil Steril"},{"issue":"4","key":"10.1016\/j.ejogrb.2004.06.024_bib31","first-page":"1589","volume":"86","author":"Elting","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.ejogrb.2004.06.024_bib32","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1677\/jme.0.0060171","article-title":"Inverse effects of activin and inhibin on the synthesis and secretion of FSH and LH by ovine pituitary cells in vitro","volume":"6","author":"Muttukrishna","year":"1991","journal-title":"J Mol Endocrinol"},{"issue":"6","key":"10.1016\/j.ejogrb.2004.06.024_bib33","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1002\/j.1939-4640.1992.tb00348.x","article-title":"Differential regulation in the release of bioactive versus immunoactive gonadotropins from cultured rat pituitary cells by inhibin and androgens","volume":"13","author":"Dahl","year":"1992","journal-title":"J Androl"},{"issue":"11","key":"10.1016\/j.ejogrb.2004.06.024_bib34","doi-asserted-by":"crossref","first-page":"5541","DOI":"10.1210\/jcem.86.11.8031","article-title":"Importance of inhibin B in the regulation of FSH secretion in the human male","volume":"86","author":"Hayes","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.ejogrb.2004.06.024_bib35","first-page":"1287","article-title":"A syndrome of female pseudohermaphrodism, hypergonadotropic hypogonadism, and multicystic ovaries associated with missense mutations in the gene encoding aromatase (P450arom)","volume":"78","author":"Conte","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.ejogrb.2004.06.024_bib36","first-page":"898","article-title":"Combined 17alpha-Hydroxylase\/17,20-lyase deficiency caused by Phe93Cys mutation in the CYP17 gene","volume":"87","author":"Di Cerbo","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.ejogrb.2004.06.024_bib37","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1093\/oxfordjournals.humrep.a019059","article-title":"Ovarian hyperstimulation syndrome with low oestradiol in non-classical 17-alpha-hydroxylase, 17,20-lyase deficiency: what is the role of oestrogens?","volume":"11","author":"Meirow","year":"1996","journal-title":"Hum Reprod"},{"issue":"2","key":"10.1016\/j.ejogrb.2004.06.024_bib38","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/S0015-0282(02)03241-7","article-title":"A randomized double-blind comparison of the effects of clomiphene citrate and the aromatase inhibitor letrozole on ovulatory function in normal women","volume":"78","author":"Fisher","year":"2002","journal-title":"Fertil Steril"},{"issue":"3","key":"10.1016\/j.ejogrb.2004.06.024_bib39","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/00001703-200206000-00003","article-title":"Aromatase inhibition for ovarian stimulation: future avenues for infertility management","volume":"14","author":"Mitwally","year":"2002","journal-title":"Curr Opin Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.ejogrb.2004.06.024_bib40","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0015-0282(00)01705-2","article-title":"Use of an aromatase inhibitor for induction of ovulation in patients with an inadequate response to clomiphene citrate","volume":"75","author":"Mitwally","year":"2001","journal-title":"Fertil Steril"},{"issue":"11","key":"10.1016\/j.ejogrb.2004.06.024_bib41","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1023\/A:1013165006406","article-title":"Improved responsiveness of PCOS patients to clomiphene after CYP17a inhibitor","volume":"18","author":"Ali Hassan","year":"2001","journal-title":"J Assist Reprod Genet"},{"issue":"4","key":"10.1016\/j.ejogrb.2004.06.024_bib42","first-page":"1158","article-title":"Hypersecretion of androstenedione by isolated thecal cells from polycystic ovaries","volume":"79","author":"Gilling-Smith","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.ejogrb.2004.06.024_bib43","first-page":"4103","volume":"81","author":"Ibanez","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.ejogrb.2004.06.024_bib44","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1093\/humrep\/12.7.1416","article-title":"A pilot study of the human chorionic gonadotrophin test for ovarian hyperandrogenism","volume":"12","author":"Levrant","year":"1997","journal-title":"Hum Reprod"},{"issue":"1","key":"10.1016\/j.ejogrb.2004.06.024_bib45","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1046\/j.1365-2265.1997.2321049.x","article-title":"Evidence for a primary abnormality of thecal cell steroidogenesis in the polycystic ovary syndrome","volume":"47","author":"Gilling-Smith","year":"1997","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"10.1016\/j.ejogrb.2004.06.024_bib46","doi-asserted-by":"crossref","first-page":"E902","DOI":"10.1152\/ajpendo.00415.2003","article-title":"Exaggerated 17-hydroxyprogesterone response to intravenous infusions of recombinant human LH in women with polycystic ovary syndrome","volume":"286","author":"McCartney","year":"2004","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.ejogrb.2004.06.024_bib47","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1210\/er.16.3.322","article-title":"Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion","volume":"16","author":"Ehrmann","year":"1995","journal-title":"Endocr Rev"},{"issue":"12","key":"10.1016\/j.ejogrb.2004.06.024_bib48","first-page":"3689","article-title":"Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens","volume":"80","author":"Morishima","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.ejogrb.2004.06.024_bib49","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1056\/NEJM199708283370905","article-title":"Delayed puberty and hypogonadism caused by mutations in the follicle-stimulating hormone beta-subunit gene","volume":"337","author":"Layman","year":"1997","journal-title":"N Engl J Med"},{"issue":"26","key":"10.1016\/j.ejogrb.2004.06.024_bib50","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1056\/NEJM197212282872602","article-title":"Isolated deficiency of follicle-stimulating hormone. Clinical and laboratory features","volume":"287","author":"Rabin","year":"1972","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.ejogrb.2004.06.024_bib51","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/ng0993-83","article-title":"Primary amenorrhoea and infertility due to a mutation in the beta-subunit of follicle-stimulating hormone","volume":"5","author":"Matthews","year":"1993","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.ejogrb.2004.06.024_bib52","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1093\/humrep\/17.1.88","article-title":"The role of LH and FSH in ovarian androgen secretion and ovarian follicular development: clinical studies in a patient with isolated FSH deficiency and multicystic ovaries","volume":"17","author":"Barnes","year":"2002","journal-title":"Hum Reprod"},{"issue":"4","key":"10.1016\/j.ejogrb.2004.06.024_bib53","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1210\/jc.2002-021280","article-title":"Evidence for abnormal granulosa cell responsiveness to follicle-stimulating hormone in women with polycystic ovary syndrome","volume":"88","author":"Coffler","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"1\u20132","key":"10.1016\/j.ejogrb.2004.06.024_bib54","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0303-7207(01)00611-6","article-title":"Hypothalamic dysfunction","volume":"183","author":"Marshall","year":"2001","journal-title":"Mol Cell Endocrinol"},{"issue":"3","key":"10.1016\/j.ejogrb.2004.06.024_bib55","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1210\/endo.135.3.8070381","article-title":"Gonadotropin-releasing hormone pulse frequency regulates expression of pituitary follistatin messenger ribonucleic acid: a mechanism for differential gonadotrope function","volume":"135","author":"Kirk","year":"1994","journal-title":"Endocrinology"},{"issue":"6","key":"10.1016\/j.ejogrb.2004.06.024_bib56","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S1043-2760(02)00614-8","article-title":"The nature of FSH induction by GnRH","volume":"13","author":"Miller","year":"2002","journal-title":"Trends Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.ejogrb.2004.06.024_bib57","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1093\/humrep\/16.12.2552","article-title":"Follistatin and activin A serum concentrations in obese and non-obese patients with polycystic ovary syndrome","volume":"16","author":"Eldar-Geva","year":"2001","journal-title":"Hum Reprod"},{"issue":"7","key":"10.1016\/j.ejogrb.2004.06.024_bib58","first-page":"2343","article-title":"Use of a gonadotropin-releasing hormone antagonist as a physiologic probe in polycystic ovary syndrome: assessment of neuroendocrine and androgen dynamics","volume":"83","author":"Hayes","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.ejogrb.2004.06.024_bib59","first-page":"582","article-title":"Polycystic ovary syndrome: evidence for reduced sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone","volume":"83","author":"Pastor","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.ejogrb.2004.06.024_bib60","first-page":"4047","article-title":"Polycystic ovarian syndrome: evidence that flutamide restores sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone","volume":"85","author":"Eagleson","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.ejogrb.2004.06.024_bib61","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1365-2265.2004.01945.x","article-title":"Relationship of GnRH-stimulated LH release to episodic LH secretion and baseline endocrine-metabolic measures in women with polycystic ovary syndrome","volume":"60","author":"Patel","year":"2004","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"10.1016\/j.ejogrb.2004.06.024_bib62","first-page":"893","article-title":"The neuroendocrine regulation of the human ovarian cycle","volume":"18","author":"Buffet","year":"2001","journal-title":"Chronobiol Int"},{"issue":"3","key":"10.1016\/j.ejogrb.2004.06.024_bib63","first-page":"851","article-title":"A two-site chemiluminescent assay for activin-free follistatin reveals that most follistatin circulating in men and normal cycling women is in an activin-bound state","volume":"83","author":"McConnell","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.ejogrb.2004.06.024_bib64","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1530\/eje.0.1450619","article-title":"Receiver operating characteristic analysis of the performance of basal serum hormone profiles for the diagnosis of polycystic ovary syndrome in epidemiological studies","volume":"145","author":"Escobar-Morreale","year":"2001","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"10.1016\/j.ejogrb.2004.06.024_bib65","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/humrep\/deh103","article-title":"Six-month treatment with low-dose dexamethasone further reduces androgen levels in PCOS women treated with diet and lifestyle advice, and metformin","volume":"19","author":"Vanky","year":"2004","journal-title":"Hum Reprod"},{"issue":"10","key":"10.1016\/j.ejogrb.2004.06.024_bib66","doi-asserted-by":"crossref","first-page":"5060","DOI":"10.1210\/jcem.86.10.7900","article-title":"The postmenopausal ovary is not a major androgen-producing gland","volume":"86","author":"Couzinet","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.ejogrb.2004.06.024_bib67","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1046\/j.1365-2265.2000.01017.x","article-title":"Oral dehydroepiandrosterone (DHEA) replacement therapy in women with Addison's disease","volume":"52","author":"Gebre-Medhin","year":"2000","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"10.1016\/j.ejogrb.2004.06.024_bib68","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1093\/humrep\/17.3.620","article-title":"Ovarian and adrenal steroid production: regulatory role of LH\/HCG","volume":"17","author":"Piltonen","year":"2002","journal-title":"Hum Reprod"},{"issue":"4","key":"10.1016\/j.ejogrb.2004.06.024_bib69","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/S0015-0282(16)56219-0","article-title":"Determination of the steroidogenic capacity in premature ovarian failure","volume":"60","author":"Bermudez","year":"1993","journal-title":"Fertil Steril"},{"issue":"4","key":"10.1016\/j.ejogrb.2004.06.024_bib70","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1093\/humrep\/17.4.933","article-title":"Progesterone serum levels during the follicular phase of the menstrual cycle originate from the crosstalk between the ovaries and the adrenal cortex","volume":"17","author":"De Geyter","year":"2002","journal-title":"Hum Reprod"},{"issue":"6","key":"10.1016\/j.ejogrb.2004.06.024_bib71","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/0002-9378(74)90490-6","article-title":"Effect of oophorectomy on circulating testosterone and androstenedione levels in patients with endometrial cancer","volume":"118","author":"Judd","year":"1974","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.ejogrb.2004.06.024_bib72","first-page":"1512","article-title":"Age effects of follicle-stimulating hormone and pulsatile luteinizing hormone secretion across the menstrual cycle of premenopausal women","volume":"81","author":"Reame","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.ejogrb.2004.06.024_bib73","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/S0002-9378(98)70483-1","article-title":"Effects of aging and gonadal failure on the hypothalamic-pituitary axis in women","volume":"178","author":"Santoro","year":"1998","journal-title":"Am J Obstet Gynecol"},{"issue":"10","key":"10.1016\/j.ejogrb.2004.06.024_bib74","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1093\/humrep\/17.10.2535","article-title":"Serum inhibins, estradiol, progesterone and FSH in surgical menopause: a demonstration of ovarian pituitary feedback loop in women","volume":"17","author":"Muttukrishna","year":"2002","journal-title":"Hum Reprod"},{"issue":"10","key":"10.1016\/j.ejogrb.2004.06.024_bib75","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1093\/humrep\/17.10.2540","article-title":"In-vivo ovarian androgen responses to recombinant FSH with and without recombinant LH in polycystic ovarian syndrome","volume":"17","author":"Cheung","year":"2002","journal-title":"Hum Reprod"},{"issue":"14","key":"10.1016\/j.ejogrb.2004.06.024_bib76","doi-asserted-by":"crossref","first-page":"5082","DOI":"10.1073\/pnas.84.14.5082","article-title":"Heterodimers and homodimers of inhibin subunits have different paracrine action in the modulation of luteinizing hormone-stimulated androgen biosynthesis","volume":"84","author":"Hsueh","year":"1987","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"10.1016\/j.ejogrb.2004.06.024_bib77","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1210\/endo.133.4.8404591","article-title":"Ovarian thecal\/interstitial androgen synthesis is enhanced by a follicle-stimulating hormone-stimulated paracrine mechanism","volume":"133","author":"Smyth","year":"1993","journal-title":"Endocrinology"},{"issue":"16","key":"10.1016\/j.ejogrb.2004.06.024_bib78","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1056\/NEJM200010193431614","article-title":"Effect of follicle-stimulating hormone on ovarian androgen production in a woman with isolated follicle-stimulating hormone deficiency","volume":"343","author":"Barnes","year":"2000","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.ejogrb.2004.06.024_bib79","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1093\/humrep\/deg244","article-title":"Ovarian stromal blood flow changes after laparoscopic ovarian cauterization in women with polycystic ovary syndrome","volume":"18","author":"Parsanezhad","year":"2003","journal-title":"Hum Reprod"},{"issue":"5","key":"10.1016\/j.ejogrb.2004.06.024_bib80","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1067\/S0002-9378(03)00832-9","article-title":"Does ovarian blood flow distinguish between ovulatory and anovulatory patients with polycystic ovary syndrome?","volume":"189","author":"Carmina","year":"2003","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.ejogrb.2004.06.024_bib81","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1530\/eje.0.1430383","article-title":"Ovarian\u2013adrenal cross-talk in polycystic ovary syndrome: evidence from wedge resection","volume":"143","author":"Wu","year":"2000","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"10.1016\/j.ejogrb.2004.06.024_bib82","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1385\/ENDO:16:3:151","article-title":"Recent discoveries in physiology of insulin-like growth factor-1 and its interaction with gonadotropins in folliculogenesis","volume":"16","author":"Khamsi","year":"2001","journal-title":"Endocrine"},{"issue":"2","key":"10.1016\/j.ejogrb.2004.06.024_bib83","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1172\/JCI114745","article-title":"Insulin-like growth factor-I enhances luteinizing hormone binding to rat ovarian theca-interstitial cells","volume":"86","author":"Cara","year":"1990","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.ejogrb.2004.06.024_bib84","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1210\/jcem-73-3-590","article-title":"Acanthosis Nigricans, insulin action, and hyperandrogenism: clinical, histological, and biochemical findings","volume":"73","author":"Dunaif","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.ejogrb.2004.06.024_bib85","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/01.OGX.0000109523.25076.E2","article-title":"Detecting insulin resistance in polycystic ovary syndrome: purposes and pitfalls","volume":"59","author":"Legro","year":"2004","journal-title":"Obstet Gynecol Surv"},{"issue":"2","key":"10.1016\/j.ejogrb.2004.06.024_bib86","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1365-2265.2004.01973.x","article-title":"Effect of flutamide and metformin administered alone or in combination in dieting obese women with polycystic ovary syndrome","volume":"60","author":"Gambineri","year":"2004","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"9099","key":"10.1016\/j.ejogrb.2004.06.024_bib87","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0140-6736(05)78345-8","article-title":"Insulin-sensitising agents in polycystic ovary syndrome","volume":"351","author":"Sattar","year":"1998","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.ejogrb.2004.06.024_bib88","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1093\/humrep\/17.9.2230","article-title":"Should patients with polycystic ovarian syndrome be treated with metformin?","volume":"17","author":"Seli","year":"2002","journal-title":"Hum Reprod"},{"issue":"3","key":"10.1016\/j.ejogrb.2004.06.024_bib89","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/gye.16.3.217.224","article-title":"Clinical and endocrinological effects of 6 months of metformin treatment in young hyperinsulinemic patients affected by polycystic ovary syndrome","volume":"16","author":"Loverro","year":"2002","journal-title":"Gynecol Endocrinol"},{"issue":"7","key":"10.1016\/j.ejogrb.2004.06.024_bib90","first-page":"2108","article-title":"Troglitazone improves defects in insulin action, insulin secretion, ovarian steroidogenesis, and fibrinolysis in women with polycystic ovary syndrome","volume":"82","author":"Ehrmann","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.ejogrb.2004.06.024_bib91","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0015-0282(98)00454-3","article-title":"Effect of troglitazone on endocrine and ovulatory performance in women with insulin resistance-related polycystic ovary syndrome","volume":"71","author":"Hasegawa","year":"1999","journal-title":"Fertil Steril"},{"issue":"3","key":"10.1016\/j.ejogrb.2004.06.024_bib92","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0015-0282(16)49211-3","article-title":"Persistence of insulin resistance in polycystic ovarian disease after inhibition of ovarian steroid secretion","volume":"45","author":"Geffner","year":"1986","journal-title":"Fertil Steril"},{"issue":"11","key":"10.1016\/j.ejogrb.2004.06.024_bib93","first-page":"921","article-title":"Persistent insulin resistance after normalization of androgen levels in a woman with congenital adrenal hyperplasia. A case report","volume":"34","author":"Singer","year":"1989","journal-title":"J Reprod Med"},{"issue":"6","key":"10.1016\/j.ejogrb.2004.06.024_bib94","first-page":"1747","article-title":"Regulation of extragonadal insulin-like growth factor-binding protein-3 by testosterone in oophorectomized women","volume":"79","author":"Azziz","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.ejogrb.2004.06.024_bib95","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1210\/jcem-68-6-1027","article-title":"Suppression of serum insulin by diazoxide reduces serum testosterone levels in obese women with polycystic ovary syndrome","volume":"68","author":"Nestler","year":"1989","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.ejogrb.2004.06.024_bib96","first-page":"3299","article-title":"The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome","volume":"81","author":"Dunaif","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.ejogrb.2004.06.024_bib97","doi-asserted-by":"crossref","first-page":"4088","DOI":"10.1210\/jc.2002-020363","article-title":"Decreased insulin receptor (IR) autophosphorylation in fibroblasts from patients with PCOS: effects of serine kinase inhibitors and IR activators","volume":"87","author":"Li","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.ejogrb.2004.06.024_bib98","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0889-8529(05)70073-6","article-title":"Insulin action in the polycystic ovary syndrome","volume":"28","author":"Dunaif","year":"1999","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"1\u20132","key":"10.1016\/j.ejogrb.2004.06.024_bib99","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0303-7207(98)00176-2","article-title":"Insulin resistance in polycystic ovary syndrome: treating a phenotype without a genotype","volume":"145","author":"Legro","year":"1998","journal-title":"Mol Cell Endocrinol"},{"issue":"1","key":"10.1016\/j.ejogrb.2004.06.024_bib100","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1210\/jcem-72-1-83","article-title":"A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome","volume":"72","author":"Nestler","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"issue":"5593","key":"10.1016\/j.ejogrb.2004.06.024_bib101","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/265421a0","article-title":"Epidermal growth factor and the multiplication of cultured human epidermal keratinocytes","volume":"265","author":"Rheinwald","year":"1977","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.ejogrb.2004.06.024_bib102","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1210\/jcem-72-4-883","article-title":"Effect of acute physiological elevations of insulin on circulating androgen levels in nonobese women","volume":"72","author":"Diamond","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.ejogrb.2004.06.024_bib103","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1210\/jcem-64-1-180","article-title":"The effects of hyperinsulinemia on serum testosterone, progesterone, dehydroepiandrosterone sulfate, and cortisol levels in normal women and in a woman with hyperandrogenism, insulin resistance, and acanthosis nigricans","volume":"64","author":"Nestler","year":"1987","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.ejogrb.2004.06.024_bib104","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1210\/edrv-12-1-3","article-title":"On the paradox of insulin-induced hyperandrogenism in insulin-resistant states","volume":"12","author":"Poretsky","year":"1991","journal-title":"Endocr Rev"},{"issue":"2","key":"10.1016\/j.ejogrb.2004.06.024_bib105","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0015-0282(16)47243-2","article-title":"Effects of insulin on steroidogenesis in cultured porcine ovarian theca","volume":"40","author":"Barbieri","year":"1983","journal-title":"Fertil Steril"},{"issue":"4","key":"10.1016\/j.ejogrb.2004.06.024_bib106","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/S0015-0282(03)01007-0","article-title":"Selective ovary resistance to insulin signaling in women with polycystic ovary syndrome","volume":"80","author":"Wu","year":"2003","journal-title":"Fertil Steril"},{"issue":"1\u20132","key":"10.1016\/j.ejogrb.2004.06.024_bib107","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0303-7207(01)00469-5","article-title":"Gonadotropic control of ovarian follicular growth and development","volume":"179","author":"Hillier","year":"2001","journal-title":"Mol Cell Endocrinol"},{"issue":"12","key":"10.1016\/j.ejogrb.2004.06.024_bib108","first-page":"1561","article-title":"Regulation of insulin-like growth factor-I (IGF-I) and IGF-binding protein 1 gene transcription by hormones and provision of amino acids in rat hepatocytes","volume":"7","author":"Pao","year":"1993","journal-title":"Mol Endocrinol"},{"issue":"2","key":"10.1016\/j.ejogrb.2004.06.024_bib109","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1210\/endo-122-2-581","article-title":"The effects of experimental hyperinsulinemia on steroid secretion, ovarian","volume":"122","author":"Poretsky","year":"1988","journal-title":"Endocrinology"},{"issue":"4","key":"10.1016\/j.ejogrb.2004.06.024_bib110","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1210\/jcem.85.4.6560","article-title":"Effect of metformin on insulin-like growth factor (IGF) I and IGF- binding protein I in polycystic ovary syndrome","volume":"85","author":"De Leo","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.ejogrb.2004.06.024_bib111","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1016\/0303-7207(91)90234-J","article-title":"Effect of recombinant inhibin on androgen synthesis in cultured human thecal cells","volume":"75","author":"Hillier","year":"1991","journal-title":"Mol Cell Endocrinol"},{"issue":"1","key":"10.1016\/j.ejogrb.2004.06.024_bib112","first-page":"330","article-title":"Differential regulation of inhibin B and inhibin a by follicle- stimulating hormone and local growth factors in human granulosa cells from small antral follicles","volume":"86","author":"Welt","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.ejogrb.2004.06.024_bib113","first-page":"641","article-title":"Insulin-like growth factors and ovarian follicular development","volume":"13","author":"Giudice","year":"1992","journal-title":"Endocr Rev"},{"issue":"5","key":"10.1016\/j.ejogrb.2004.06.024_bib114","first-page":"1411","article-title":"Expression of insulin-like growth factor-I (IGF-I) and IGF-II and the IGF-I, IGF-II, and insulin receptor genes and localization of the gene products in the human ovary","volume":"77","author":"el-Roeiy","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.ejogrb.2004.06.024_bib115","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1210\/jcem.87.1.8143","article-title":"Elevated free IGF-I levels in prepubertal Hispanic girls with premature adrenarche: relationship with hyperandrogenism and insulin sensitivity","volume":"87","author":"Silfen","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.ejogrb.2004.06.024_bib116","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1093\/oxfordjournals.humrep.a137577","article-title":"The role of insulin-like growth factor-1 (IGF-1) and IGF binding protein-1 (IGFBP-1) in the pathogenesis of polycystic ovary syndrome","volume":"7","author":"Homburg","year":"1992","journal-title":"Hum Reprod"},{"issue":"1","key":"10.1016\/j.ejogrb.2004.06.024_bib117","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0015-0282(16)56036-1","article-title":"Serum levels of insulin-like growth factor binding protein-1 and ovulatory responses to clomiphene citrate in women with polycystic ovarian disease","volume":"60","author":"Tiitinen","year":"1993","journal-title":"Fertil Steril"},{"issue":"8","key":"10.1016\/j.ejogrb.2004.06.024_bib118","first-page":"2854","article-title":"Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features","volume":"81","author":"Morales","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.ejogrb.2004.06.024_bib119","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0889-8529(05)70072-4","article-title":"Growth factor action on ovarian function in polycystic ovary syndrome","volume":"28","author":"Giudice","year":"1999","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"12","key":"10.1016\/j.ejogrb.2004.06.024_bib120","doi-asserted-by":"crossref","first-page":"5925","DOI":"10.1210\/jcem.86.12.8088","article-title":"The biochemical basis for increased testosterone production in theca cells propagated from patients with polycystic ovary syndrome","volume":"86","author":"Nelson","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.ejogrb.2004.06.024_bib121","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1210\/jc.2003-030934","article-title":"The hormonal phenotype of nonclassic 3 beta-hydroxysteroid dehydrogenase (HSD3B) deficiency in hyperandrogenic females is associated with insulin-resistant polycystic ovary syndrome and is not a variant of inherited HSD3B2 deficiency","volume":"89","author":"Carbunaru","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.ejogrb.2004.06.024_bib122","doi-asserted-by":"crossref","first-page":"3762","DOI":"10.1210\/jc.2003-030143","article-title":"The 17,20-lyase activity of cytochrome p450c17 from human fetal testis favors the delta5 steroidogenic pathway","volume":"88","author":"Fluck","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"22","key":"10.1016\/j.ejogrb.2004.06.024_bib123","doi-asserted-by":"crossref","first-page":"5608","DOI":"10.1046\/j.1432-1033.2002.03268.x","article-title":"Baboon cytochrome P45017alpha-hydroxylase\/17,20-lyase (CYP17)","volume":"269","author":"Swart","year":"2002","journal-title":"Eur J Biochem"},{"issue":"3","key":"10.1016\/j.ejogrb.2004.06.024_bib124","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0015-0282(02)03303-4","article-title":"Evidence for competing effects of body mass, hyperinsulinemia, insulin resistance, and androgens on leptin levels among lean, overweight, and obese women with polycystic ovary syndrome","volume":"78","author":"Remsberg","year":"2002","journal-title":"Fertil Steril"},{"issue":"11","key":"10.1016\/j.ejogrb.2004.06.024_bib125","first-page":"3728","article-title":"Inappropriate gonadotropin secretion in polycystic ovary syndrome: influence of adiposity","volume":"82","author":"Arroyo","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.ejogrb.2004.06.024_bib126","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/j.1365-2265.1993.tb02144.x","article-title":"Roles of LH and insulin resistance in lean and obese polycystic ovary syndrome","volume":"38","author":"Grulet","year":"1993","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"10.1016\/j.ejogrb.2004.06.024_bib127","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0015-0282(16)55249-2","article-title":"Body weight, hyperinsulinemia, and gonadotropin levels in the polycystic ovarian syndrome: evidence of two distinct populations","volume":"58","author":"Dale","year":"1992","journal-title":"Fertil Steril"},{"issue":"2","key":"10.1016\/j.ejogrb.2004.06.024_bib128","doi-asserted-by":"crossref","first-page":"166","DOI":"10.3109\/00016349609033311","article-title":"Different responses of insulin, C-peptide, and testosterone to an oral glucose tolerance test in two groups of women with polycystic ovarian syndrome","volume":"75","author":"Ke","year":"1996","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.ejogrb.2004.06.024_bib129","first-page":"131","article-title":"Incidence of elevated LH\/FSH ratio in polycystic ovary syndrome women with normo- and hyperinsulinemia","volume":"48","author":"Banaszewska","year":"2003","journal-title":"Rocz Akad Med Bialymst"},{"issue":"2","key":"10.1016\/j.ejogrb.2004.06.024_bib130","first-page":"65","article-title":"Insulin resistance in nonobese patients with polycystic ovary syndrome","volume":"55","author":"Toprak","year":"2001","journal-title":"Horm Res"},{"issue":"3","key":"10.1016\/j.ejogrb.2004.06.024_bib131","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/BF03349856","article-title":"Gonadotropin levels in women with polycystic ovary syndrome: their relationship to body weight and insulin levels","volume":"19","author":"Tropeano","year":"1996","journal-title":"J Endocrinol Invest"},{"issue":"2","key":"10.1016\/j.ejogrb.2004.06.024_bib132","first-page":"556","article-title":"17 alpha-Hydroxyprogesterone responses to leuprolide and serum androgens in obese women with and without polycystic ovary syndrome offer dietary weight loss","volume":"82","author":"Jakubowicz","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.ejogrb.2004.06.024_bib133","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.fertnstert.2003.05.027","article-title":"Increased growth hormone response to clonidine in nonobese normoinsulinemic patients with polycystic ovary syndrome","volume":"81","author":"Comim","year":"2004","journal-title":"Fertil Steril"},{"issue":"3","key":"10.1016\/j.ejogrb.2004.06.024_bib134","first-page":"149","article-title":"Inhibition of growth hormone excess reduces insulin resistance and ovarian dysfunction in a lean case of polycystic ovary syndrome with a growth-hormone-producing pituitary adenoma","volume":"59","author":"Hashimoto","year":"2003","journal-title":"Horm Res"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211504003628?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211504003628?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T05:13:14Z","timestamp":1759554794000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211504003628"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1]]},"references-count":134,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,1]]}},"alternative-id":["S0301211504003628"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2004.06.024","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2005,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PCOS: an ovarian disorder that leads to dysregulation in the hypothalamic\u2013pituitary\u2013adrenal axis?","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2004.06.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}